APRE
Aprea Therapeutics, Inc. Common stockstockNASDAQ
Market OpenNov 16, 2026 10:00:07 AM EST
0.43USD+2.427%(+0.01)77,036
Pre-marketNov 16, 2026 8:24:30 AM EST
0.428USD+2.835%(+0.012)
APRE Financials
In Q3 FY 2026 (ended ), Aprea Therapeutics, Inc. Common stock (APRE) reported net income of −$4.81M, operating cash flow of −$3.73M, and assets of $38.81M (filed ).
Loading financial statements…